Elisabeth Leiderman - 25 Feb 2022 Form 4 Insider Report for Decibel Therapeutics, Inc.

Role
Chief Financial Officer
Signature
/s/ Elisabeth Leiderman
Issuer symbol
N/A
Transactions as of
25 Feb 2022
Net transactions value
$0
Form type
4
Filing time
28 Feb 2022, 15:37:54 UTC
Previous filing
16 Nov 2021
Next filing
23 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DBTX Stock Options (right to buy) Award $0 +52,500 $0.000000 52,500 25 Feb 2022 Common Stock 52,500 $3.50 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted on February 25, 2022. The shares underlying the option are scheduled to vest with respect to 25% of the shares on February 25, 2023 and with respect to the remainder in 36 equal monthly installments thereafter through February 25, 2026.